Literature DB >> 23386549

Inhibition of hepatitis B virus-associated liver cancer by antiplatelet therapy: a revolution in hepatocellular carcinoma prevention?

Diego F Calvisi1.   

Abstract

Entities:  

Year:  2013        PMID： 23386549     DOI： 10.1002/hep.26136

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  The value of contrast-enhanced ultrasound in predicting postoperative recurrence of hepatocellular carcinoma: A protocol for systematic review and meta-analysis.

Authors:  Jieying Fu; Jia Tang; Huan Luo; Wencui Wu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

2.  Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors.

Authors:  Jia-Cheng Lu; Hai-Ying Zeng; Qi-Man Sun; Qing-Nan Meng; Xiao-Yong Huang; Peng-Fei Zhang; Xuan Yang; Rui Peng; Chao Gao; Chuan-Yuan Wei; Ying-Hao Shen; Jia-Bing Cai; Rui-Zhao Dong; Ying-Hong Shi; Hui-Chuan Sun; Yujiang G Shi; Jian Zhou; Jia Fan; Ai-Wu Ke; Liu-Xiao Yang; Guo-Ming Shi
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.